Open access publisher BioMed Central, UK, has announced the appointment of Bev Acreman as Commercial Director. Acreman comes to BioMed Central from Taylor & Francis, where she has played a significant role in growing the company to its present position as a major player in STM publishing.
With the proven success of the open access publishing model, BioMed Central is experiencing rapid growth in manuscript submissions, has many exciting new products in development and sees many opportunities for exciting partnerships and relationships with academic institutions, libraries and societies. In her new role, Acreman will use her wide experience of STM publishing to ensure that BioMed Central continues to lead the way in delivering excellent service to authors, readers and institutional customers. Her extensive previous involvement with learned society journal publishing will be a major asset as BioMed Central continues to develop its own rapidly expanding society publishing programme.
BioMed Central is an STM publisher which has pioneered the open access publishing model. All peer-reviewed research articles published by BioMed Central are made immediately and freely accessible online, and are licensed to allow redistribution and reuse. BioMed Central is part of Springer Science+Business Media.
Discuss this NEWS
More News in this Theme
